Jupiter Life Line Hospitals
- Market cap
- ₹ 7,974 Cr.
- P/E
- 44.3x
- P/B
- 5.16x
- 52-week range
- 233.4 – 340
- ROE
- 13%
- ROCE
- 15%
- Dividend yield
- 0.1%
- Debt / equity
- 0.38
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE, BSE
About
Jupiter Life Line Hospitals Limited is an India-based holding company. The Company is a multi-specialty tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India. The Company has a total bed capacity of approximately 1,061 hospital beds across three hospitals. The Company operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. It is equipped with over 30 specialty treatments, such as bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, gastroenterology, infectious diseases, internal medicine, mental health, nephrology, neurology, neurosurgery, and nutrition and dietetics. The Company also owns Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company's subsidiaries include Jupiter Hospital Projects Private Limited and Medulla Healthcare Private Limited.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Jupiter Life Line Hospitals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)44.3 against a typical 48.9: cheaper than most peers (1st = cheapest).19th of 40
- Sales growth+15.7% against a typical +21.1% from a year earlier.23rd of 34
- Profit growth−1.8% against a typical +13% from a year earlier.25th of 31
- Share price, 3 months−21.8% against a typical −10.9%.30th of 34
- Size₹ 7,973.9 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).12th of 36
Latest announcements
Exchange filings and their impact on the company.
- Jupiter to buy ~11,452 sqm Pune (Bibvewadi) land for Rs 150 cr for future hospital expansion.
Jupiter Life Line Hospitals' board on October 23, 2026 approved Q2/H1 FY27 results, incorporation of a wholly owned subsidiary, and purchase of ~11,452 sqm land at Bibvewadi, Pune for Rs 150 crore. The land deal follows its February 2026 South Pune lease announcement and is for a future hospital project. It is a pre-revenue expansion that raises near-term capex and funding outflow but strengthens the long-term Pune growth pipeline.
- Jupiter pledged assets to HDFC Bank for new capex debt of undisclosed size, adding modest leverage.
Jupiter Life Line Hospitals said it signed a hypothecation agreement with HDFC Bank on October 18, 2026 to finance its capital expenditure. No loan amount, rate, tenure or security details were disclosed in the filing. The borrowing will likely add modest leverage to fund hospital capex, with interest costs in the next year ahead of any revenue benefit.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA- by ICRA- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| ICRA | [ICRA]AA- | Stable | 10 Mar 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 10 Mar 2026 | Reaffirmed | [ICRA]AA- | — | ICRA | ₹ 718 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 23 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 31 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 15 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 30 Jan 2026 | Financial Results | Prior Intimation of the Board Meeting to be held on Friday, January 30, 2026 |
| 7 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 1 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 273 | 291 | 289 | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 | 456 |
| Expenses | 211 | 228 | 223 | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 | 350 |
| Operating Profit | 62 | 63 | 65 | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 | 107 |
| OPM % | 23% | 22% | 23% | 23% | 23% | 24% | 22% | 23% | 23% | 23% | 19% | 23% |
| Other Income | 8 | 10 | 7 | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 | 11 |
| Interest | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 | 14 |
| Depreciation | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 | 28 |
| Profit before tax | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 | 75 |
| Tax % | 25% | 27% | 26% | 26% | 22% | 28% | 29% | 23% | 25% | 26% | 26% | 25% |
| Net Profit | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 | 56 |
| EPS in Rs | 1.33 | 1.37 | 1.36 | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.3 | 1.53 | 1.14 | 1.71 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 25%
- 3 Years
- 19%
- TTM
- 14%
- 10 Years
- —
- 5 Years
- 143%
- 3 Years
- 37%
- TTM
- −4%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 7%
- TTM
- —
- 10 Years
- —
- 5 Years
- 17%
- 3 Years
- 16%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Jupiter Life Line Hospitals | ₹ 255.95 | ₹ 7,974 Cr. | 44.3x | 5.2x | 13% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 65.8x | 13.6x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 70.9x | 9.8x | 14.3% | 17.2% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 67.8x | 7.3x | 11.1% | 11.7% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 100x | 9x | 9.7% | 9.2% |
| Narayana Hrudayalaya | ₹ 1,667.25 | ₹ 33,862 Cr. | 46.6x | 8.8x | 19.9% | 10.3% |
Management
- Ajay Pratap Thakker
- Executive Chairman of the Board
- Ankit A. Thakker
- Chief Executive Officer, Managing Director, Executive Director
- Rajendra Patankar
- Chief Executive Officer of Pune Hospital
- Harshad Purani
- President - Administration, Head - Corporate Social Responsibility
- Shilpa Tatake
- Chief Executive Officer - Thane
- Manisha Shah
- Group Chief Human Resources Officer
- Suma Vinayak Upparatti
- Compliance Officer, Company Secretary
- Pradip Acharya
- Group Head Industrial Health
Prices are delayed and for information only. Nothing on this page is investment advice.